Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX), a specialty pharmaceutical company, today announced that Richard W. Pascoe, Somaxon’s president and chief executive officer will present at the Jefferies 2011 Global Healthcare Conference at The Grand Hyatt Hotel in New York City on Monday, June 6, at 9:00 a.m. Eastern Time. A live webcast of the presentation will be available in the Investor Relations section of the company’s website under Event Scheduler at www.somaxon.com. The webcast will be archived and accessible for 90 days following the conference. To be added to Somaxon Pharmaceuticals’ email list, please visit http://bit.ly/Somaxon-email-list. About Somaxon Pharmaceuticals, Inc. Headquartered in San Diego, CA, Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates to treat important medical conditions where there is an unmet medical need and/or high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Somaxon’s product Silenor ®, now available by prescription in the United States, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. For more information, please visit the company’s web site at www.somaxon.com.